• LAST PRICE
    34.9600
  • TODAY'S CHANGE (%)
    Trending Down-0.1900 (-0.5405%)
  • Bid / Lots
    34.9500/ 1
  • Ask / Lots
    35.3400/ 2
  • Open / Previous Close
    35.1500 / 35.1500
  • Day Range
    Low 34.9000
    High 35.2500
  • 52 Week Range
    Low 14.3050
    High 39.7900
  • Volume
    231,802
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 35.15
TimeVolumeINBX
09:32 ET234734.97
09:34 ET21534.96
09:36 ET90035.12
09:45 ET10034.99
09:52 ET20034.97
09:54 ET10035.11
09:56 ET328835.08
09:57 ET31435.15
10:01 ET21635.13
10:08 ET30635.1
10:12 ET18435.02
10:19 ET10035.04
10:24 ET21735.12
10:26 ET111935.14
10:32 ET27235.156
10:39 ET14635.2
10:42 ET40035.15
10:53 ET116535.2
10:55 ET86235.2
11:02 ET17235.175
11:04 ET20035.125
11:29 ET95235.2
11:31 ET1056135.2
11:33 ET689735.2
11:47 ET52735.187
11:49 ET62835.21
11:54 ET20035.24
12:00 ET70035.23
12:02 ET20035.24
12:07 ET30035.19
12:09 ET25735.19
12:21 ET185235.1104
12:23 ET40635.22
12:25 ET20035.12
12:30 ET13435.07
12:36 ET10035.09
12:54 ET10435.115
12:56 ET20035.08
12:57 ET20035.12
01:03 ET20035.05
01:17 ET10035.1
01:26 ET60035.08
01:28 ET75135.13
01:39 ET10035.03
01:50 ET20035.05
01:55 ET40035.06
01:57 ET60035.06
02:02 ET10035.09
02:06 ET20035.09
02:08 ET104335.11
02:09 ET34135.13
02:18 ET13435.16
02:22 ET20035.09
02:24 ET13435.07
02:26 ET10035.095
02:29 ET11235.111
02:31 ET10035.13
02:36 ET20035.15
02:40 ET20035.115
02:42 ET50035.13
02:49 ET20035.14
02:51 ET40035.125
02:56 ET10035.13
03:02 ET30035.15
03:03 ET90035.145
03:12 ET20335.12
03:16 ET20035.075
03:23 ET693835.11
03:25 ET46635.13
03:27 ET29635.11
03:30 ET39735.14
03:32 ET100035.17
03:34 ET30035.11
03:36 ET70035.12
03:38 ET55735.06
03:39 ET70035.06
03:41 ET20035.065
03:43 ET50035.065
03:45 ET140035.075
03:48 ET40735.04
03:50 ET109135.05
03:52 ET215535.01
03:54 ET1112934.98
03:56 ET401035.01
03:57 ET359035.01
03:59 ET393434.96
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesINBX
Inhibrx Inc
1.7B
-7.0x
---
United StatesAKRO
Akero Therapeutics Inc
1.7B
-8.9x
---
United StatesAUTL
Autolus Therapeutics PLC
1.7B
-5.3x
---
United StatesKURA
Kura Oncology Inc
1.6B
-10.2x
---
United StatesEWTX
Edgewise Therapeutics Inc
1.7B
-11.6x
---
United StatesMORF
Morphic Holding Inc
1.8B
-10.1x
---
As of 2024-03-29

Company Information

Inhibrx, Inc. is a clinical-stage biopharmaceutical company, which is focused on developing a broad pipeline of novel biologic therapeutic candidates. The Company’s pipeline is focused on oncology and orphan diseases. Its clinical pipeline includes therapeutic candidates, such as INBRX-101, and INBRX-109. INBRX-101 is an engineered recombinant human alpha-1 antitrypsin fragment crystallizable (AAT-Fc) fusion protein therapeutic candidate that the Company is developing for the treatment of patients with Alpha-1 Antitrypsin Deficiency (AATD) and acute Graft-versus -host-disease (aGvHD). AATD is an inherited disease that causes an increased risk of developing pulmonary disease defined by progressive loss of lung tissue and function and is associated with decreased life expectancy. INBRX-109 is an engineered tetravalent therapeutic candidate targeting death-receptor 5 (DR5), a TNFRSF member, also known as tumor necrosis factor-related apoptosis-inducing ligand or TRAIL receptor 2.

Contact Information

Headquarters
11025 N. Torrey Pines Road, Suite 200LA JOLLA, CA, United States 92037
Phone
858-795-4220
Fax
302-636-5454

Executives

Chairman of the Board of Director, President, Chief Executive Officer, Co-Founder
Mark Lappe
Co-Founder, Chief Scientific Officer
Brendan Eckelman
Chief Financial Officer
Kelly Deck
Independent Director
Douglas Forsyth
Independent Director
Jon Kayyem

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.7B
Revenue (TTM)
$1.8M
Shares Outstanding
47.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.92
EPS
$-5.03
Book Value
$0.92
P/E Ratio
-7.0x
Price/Sales (TTM)
920.5
Price/Cash Flow (TTM)
---
Operating Margin
-12,178.94%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.